Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)

NCT ID: NCT01732432

Last Updated: 2015-04-01

Basic Information

• Recruitment Status: WITHDRAWN
• Study Classification: OBSERVATIONAL
• Study Start Date: 2012-10-31
• Study Completion Date: 2013-12-31

Brief Summary

The purpose of this study is to determine whether a relationship exists between a previously established diagnosis of endometriosis and the consecutive risk of developing a clear cell or endometrioid ovarian carcinoma. All histopathological records since 1980 with these diagnoses (endometriosis, clear cell and endometrioid ovarian carcinoma) will be reviewed. Cancer registry data will be assessed to investigate differences in survival of women with endometriosis-associated ovarian carcinomas and those ovarian carcinoma patients without previous diagnosis of endometriosis.

Conditions

Endometrioid Carcinoma; Clear Cell Carcinoma; Endometriosis

Study Design

• Study Time Perspective: RETROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• endometrioid ovarian carcinoma
• clear cell ovarian carcinoma
• endometriosis, atypical endometriosis
• borderline tumors with endometriosis

Exclusion Criteria

• undifferentiated carcinomas
• germ cell tumors
• sex cord-stromal tumors

• Minimum Eligible Age: 30 Years
• Maximum Eligible Age: 85 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

University Hospital, Basel, Switzerland

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Ellen Obermann, MD, Dr.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Basel, University of Basel

Ellen C Obermann, MD

Role: PRINCIPAL_INVESTIGATOR

Institute of Pathology, University Hospital Basel, University of Basel

Other Identifiers

210/12

Identifier Type: -

Identifier Source: org_study_id